INSMED
Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is ARIKAYCE® (amikacin liposome inhalation suspension), which is approved in the United States for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. MAC lung disease is a rare and often chroni... c infection that can cause irreversible lung damage and can be fatal. Insmed's earlier-stage clinical pipeline includes INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases, and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for rare pulmonary disorders, including pulmonary arterial hypertension.
INSMED
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1988-01-01
Address:
Bridgewater, New Jersey, United States
Country:
United States
Website Url:
http://www.insmed.com
Total Employee:
501+
Status:
Active
Contact:
+1 732) 997-4600
Email Addresses:
[email protected]
Total Funding:
1.37 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2010-12-02 | Transave | Transave acquired by Insmed | N/A |
| 2000-05-31 | Celtrix Pharmaceuticals | Celtrix Pharmaceuticals acquired by Insmed | N/A |
Investors List
Forbion Capital Partners
Forbion Capital Partners investment in Post-IPO Equity - Insmed
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-23 | Insmed Names Drayton Wise Chief Commercial Officer |
| 2020-01-30 | Insmed appoints Bonstein chief financial officer |
Official Site Inspections
http://www.insmed.com Semrush global rank: 2.3 M Semrush visits lastest month: 8.16 K
- Host name: 195.126.196.104.bc.googleusercontent.com
- IP address: 104.196.126.195
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Insmed"
Insmed - Crunchbase Company Profile & Funding
Insmed's earlier-stage clinical pipeline includes INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic …See details»
Insmed Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 Insmed has 5 employees across 11 locations and $363.71 m in annual revenue in FY 2024. See insights on Insmed including office locations, competitors, revenue, financials, …See details»
Insmed - The Org
Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Industries. Biotechnology. Headquarters. Bridgewater, United States. Employees. 501 …See details»
Insmed – 2024 Annual Report
Shareholders may receive without charge a copy of our Annual Report on Form 10-K for the year ended December 31, 2024, by going to investor.insmed.com or by sending a written request to …See details»
Insmed (INSM) Company Profile & Description - Stock Analysis
700 US Highway 202/206 Bridgewater, New Jersey 08807 United StatesSee details»
Insmed Company Profile, Stock Price, News, …
As Insmed's business needs have changed and the organization has evolved, I have been given many, many opportunities to learn and grow with the company. Insmed values not only its …See details»
Investor Relations | Insmed Incorporated
6 days ago Insmed (Nasdaq:INSM) is a people-first global biopharmaceutical company on a mission to transform the lives of patients facing serious and rare diseases. Our strong and experienced management team embodies our …See details»
About Insmed - Learn About Our Values, …
An installation at Insmed’s global headquarters honors the Company’s past as we look toward the future. From the early days of the two original companies that formed Insmed to the …See details»
Culture - annualreport.insmed.com
Hosted 6 Insmed Cares volunteer events and 13 charitable team building activities; Collected 4,000+ in-kind donations; ... With this opportunity in mind, I am looking forward to providing legal …See details»
Insmed Incorporated (INSM): Among the Large-Cap Stocks …
May 4, 2025 Insmed Incorporated (NASDAQ:INSM) has a short float of 8.51%, putting the company under consistent pressure from bearish positions. Additionally, the steep 15.14% …See details»
Insmed - Leadership Team - The Org
The Leadership Team at Insmed plays a crucial role in driving the company's strategic direction and operational excellence. Comprising key executives, including the CEO, CFO, and Chief …See details»
Insmed Reports First-Quarter 2025 Financial Results and Provides ...
5 days ago Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases.See details»
INSM - Insmed Inc Latest Stock News & Market Updates
Apr 24, 2025 Insmed’s research and development efforts extend to both mid- and early-stage projects, where exploratory research into genetic therapies and other novel modalities is …See details»
Insmed Unites Across Communities Around the World During …
Oct 23, 2024 Company-wide day of service brings together more than 1,000 employees to support over 40 organizations throughout the U.S., Europe, and Japan BRIDGEWATER, N.J., …See details»
Management Team - Insmed
Sit down with members of Insmed’s global Research team as they discuss our approach to developing life-transforming medicines while tackling some of the most pressing scientific …See details»
Insmed Reports First-Quarter 2025 Financial Results and Provides ...
6 days ago Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious …See details»
Diana McCormick - annualreport.insmed.com
Mar 21, 2025 “One of the greatest strengths we have at Insmed is how we show up for each other, especially when we are trying to solve a problem or tackle a really big issue. The people …See details»
Contact Us - Insmed
Discovery Dialogues at Insmed. Sit down with members of Insmed’s global Research team as they discuss our approach to developing life-transforming medicines while tackling some of the …See details»
Our Culture - Insmed
At Insmed, we believe that every moment and every patient counts. That’s why no matter the obstacles we face, we will find a way or create one to make the greatest possible impact. …See details»
Insmed Incorporated Investor Relations - Earnings Results
Discovery Dialogues at Insmed. Sit down with members of Insmed’s global Research team as they discuss our approach to developing life-transforming medicines while tackling some of the …See details»